Campbell Newman Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-21,010
| Closed | -$1.3M | – | 119 |
|
|
2022
Q3 | $1.3M | Buy |
21,010
+500
| +2% | +$30.9K | 0.15% | 65 |
|
|
2022
Q2 | $1.64M | Buy |
20,510
+901
| +5% | +$71.9K | 0.17% | 57 |
|
|
2022
Q1 | $2.06M | Buy |
19,609
+369
| +2% | +$38.8K | 0.2% | 54 |
|
|
2021
Q4 | $2.07M | Sell |
19,240
-9,138
| -32% | -$985K | 0.18% | 58 |
|
|
2021
Q3 | $3.11M | Buy |
28,378
+1,494
| +6% | +$164K | 0.32% | 42 |
|
|
2021
Q2 | $2.52M | Buy |
26,884
+1,385
| +5% | +$130K | 0.25% | 50 |
|
|
2021
Q1 | $2.35M | Buy |
25,499
+1,220
| +5% | +$112K | 0.25% | 52 |
|
|
2020
Q4 | $1.78M | Buy |
24,279
+1,834
| +8% | +$134K | 0.2% | 55 |
|
|
2020
Q3 | $1.74M | Sell |
22,445
-9,006
| -29% | -$700K | 0.22% | 52 |
|
|
2020
Q2 | $1.75M | Buy |
31,451
+311
| +1% | +$17.3K | 0.24% | 49 |
|
|
2020
Q1 | $922K | Sell |
31,140
-1,739
| -5% | -$51.5K | 0.16% | 61 |
|
|
2019
Q4 | $1.19M | Buy |
32,879
+224
| +0.7% | +$8.11K | 0.16% | 62 |
|
|
2019
Q3 | $889K | Sell |
32,655
-247
| -0.8% | -$6.72K | 0.13% | 71 |
|
|
2019
Q2 | $792K | Buy |
32,902
+2,217
| +7% | +$53.4K | 0.12% | 75 |
|
|
2019
Q1 | $811K | Buy |
30,685
+11,821
| +63% | +$312K | 0.13% | 73 |
|
|
2018
Q4 | $369K | Buy |
+18,864
| New | +$369K | 0.06% | 110 |
|